Market reporting

Gold compound
#Alzheimer's #BioInnovation Institute #Biotech hubs #Cognition Therapeutics #India #Interview #Market reporting #Neurodegenerative disorders #Neuroscience #Pregnancy #Start-ups #Women's health

Podcast: Where are scientists making waves in drug discovery?

This is the latest episode of the free DDW narrated podcast, titled “Where are scientists making waves in drug discovery?”, which covers three articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “How pharma is targeting advances in Alzheimer’s treatments”, “The start-up disrupting… Read More

#News

USA flag
#Biotech hubs #Biotechnology #Market reporting #United States

Who should we be watching on the USA biotech stage?

Since the inauguration of President Trump in January, the United States has been constantly in the international news, but which US biotech companies are making headlines? Diana Spencer highlights five innovators. According to Cervicorn Consulting, the US biotechnology market size could reach around $1,470.82 billion by 20331  – though it… Read More

#Business & Investment #Exclusive Content #Market Reports

Virus and antibodies
#Cell Science #In Focus Report #Market reporting #Organoids

Explore our latest eReport: 3D biology and organoids

Organoids and 3D biology are revolutionising drug discovery, offering more physiologically relevant models to study diseases, screen compounds, and develop personalised treatments. These technologies provide deeper insights into human biology, bridging the gap between in vitro research and clinical success.  In 2024, the field has seen significant… Read More

#News

#Evaluate Pharma #Market reporting #Orphan drugs #Rare disease

Orphan drugs will be a fifth of prescription drug sales by 2030

Orphan drugs will make up a fifth of the forecasted $1.6 trillion in worldwide prescription drug sales by 2030, according to Evaluate’s 2025 Orphan Drug Report.  The 2025 report, based on Evaluate Pharma forecasts, projects that the segment will continue to outpace the wider pharmaceutical market for the next few… Read More

#News #Trends & Analysis

#BioInnovation Institute #Biologics / Biotechnology #Biotech hubs #Drug discovery #Funding #Investment #Life sciences #Market reporting #Start-ups #United States

New podcast: Global epicentres of drug discovery innovation

This is the latest episode of the free DDW narrated podcast, titled “Where are the global epicentres of drug discovery innovation?”, which covers two articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: Where are the hottest drug discovery hubs in the… Read More

#News

#GLP-1 #Market reporting #Novo Nordisk #Obesity #Scandinavia #Weight loss

What effect have weight loss drugs had on the Scandinavian economy?

In less than a decade GLP-1 receptor agonists have transformed the treatment of obesity and made Novo Nordisk Europe’s most valuable company. Diana Spencer explores the current impact and potential future for these drugs. Originally designed in Scandinavia as a maintenance therapy for type 2 diabetes, GLP-1 receptor agonists are… Read More

#Exclusive Content #Market Reports #Trends & Analysis

Nasdaq stock market
#Ascentage Pharma #Haematology #Market reporting #Oncology

Hong Kong based Ascentage Pharma lists on Nasdaq

Ascentage Pharma has listed on the Nasdaq Global Market, becoming the first 18A company to achieve a dual listing on the US stock market.   Ascentage Pharma offered 7,325,000 American depositary shares (ADS) at $17.25 per ADS. The proceeds from the offering are expected to be approximately $126.4 million.  The company… Read More

#Business & Investment #News

#Artificial intelligence (AI) #Automation / robotics #Lab automation #Market reporting #Survey

AI is the automation trend researchers are most excited about

When it comes to future developments in lab automation technology, the integration of artificial intelligence (AI) is the top area of anticipation for drug discovery labs.   This is one of the key findings of the DDW Research & Consultancy 2025 Research Report Purchasing in Drug Discovery Lab Automation: Forecast Trends.  … Read More

#Editor's Choice #News #Trends & Analysis

#Biopharmaceuticals #Clarivate #Market reporting #Small molecules

Eleven drugs tipped for blockbuster status by 2030

Eleven drugs are projected to achieve blockbuster status or revolutionise treatment paradigms within five years, according to Clarivate’s 2025 Drugs to Watch report.  The drugs address critical challenges in areas such as obesity, oncology, and gene therapy, and are forecast to achieve blockbuster sales by 2030 or dramatically improve patient… Read More

#Editor's Choice #News #Trends & Analysis

#Biopharmaceuticals #Business #Market reporting

Half of 2023’s new drugs underperformed in their first year

Half of the 2023 US pharmaceutical launch class underperformed their pre-launch first year forecast while 39% overperformed. However, this is an improvement from prior years, with 54% underperforming and 35% overperforming when evaluating new product launches in the US from 2020-2023. These are the findings of a whitepaper by life… Read More

#Business & Investment #Editor's Choice #News

#Artificial intelligence (AI) #Drug discovery #In Focus Report #Machine learning #Market reporting

Download the report: How AI and ML are improving drug discovery

Artificial intelligence (AI) and machine learning (ML) are helping drive efficiencies across drug discovery and development processes and represent exciting tools that teams can utilise to bring therapies to patients. Created by DDW and sponsored by Benchling, ‘AI & ML: How technology is improving drug discovery’ is a free… Read More

#News

#Artificial intelligence (AI) #Drug discovery #In Focus Report #Machine learning #Market reporting

AI and ML: How technology is improving drug discovery

Created by DDW and sponsored by Benchling, ‘AI & ML: How technology is improving drug discovery’ is a free In Focus report available to download now. Artificial intelligence (AI) and machine learning (ML) are helping drive efficiencies across drug discovery and development processes and represent exciting tools that teams can… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence

United States of America
#Biotech hubs #Biotechnology #Market reporting #North America

North American biotech innovation: Who and where?

DDW’s Diana Spencer explores some of North America’s most important life science hubs and finds out the benefits of each unique ecosystem. The United States dominates the biotech sector in North America and globally, with an estimated value share of nearly 59% in 20211. According to Key Biotechnology Indicators collated… Read More

#Exclusive Content #Market Reports